Ratings by Craig-Hallum (John Wilkin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | MDxHealth SA | MDXH | Downgrade | Hold (Buy) |
0.60 (0.19) |
-68.33% | Details | |
| 10/2/2026 | Myriad Genetics | MYGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2026 | Personalis | PSNL | Downgrade | Hold (Buy) |
18.38 (15.84) |
-13.82% | Details | |
| 5/14/2026 | MDxHealth SA | MDXH | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Myriad Genetics | MYGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2026 | Exagen | XGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2025 | Exagen | XGN | New Coverage | Buy (N/A) |
6.94 (7.53) |
8.5% | Details | |
| 7/17/2025 | MDxHealth SA | MDXH | New Coverage | Buy (N/A) |
2.20 (0.60) |
-72.73% | Details | |
| 6/18/2025 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Buy (N/A) |
10.14 (24.36) |
140.24% | Details | |
| 5/7/2025 | Myriad Genetics | MYGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2025 | Veracyte, Inc | VCYT | New Coverage | Buy (N/A) |
31.78 (46.10) |
45.06% | Details | |
| 3/17/2025 | Personalis | PSNL | New Coverage | Buy (N/A) |
3.63 (18.38) |
406.34% | Details | |
| 2/12/2025 | Myriad Genetics | MYGN | New Coverage | Buy (N/A) |
12.57 (5.45) |
-56.64% | Details |
